Abstract 411P
Background
The cancer, which claims a million deaths per annum across India is a major concern due to presentation in later stages, owing to lack of awareness and structured screening programs. The fragmented screening happens through hospitals (HBS), rural camps by screening buses (CSB), awareness programs, and augmented self-examination (ASE) protocols using AI. This research is aimed to empower cancer screening strategies.
Methods
The effective analysis is based on the number of cancer cases detected and treated effectively. Cost data were collected as a combination of CAPEX and OPEX to do a camp and cost is derived per test using key informant interviews, patient surveys, and other publicly available data sources. A hypothetical cohort of 5,00,000 patients was assumed for assessing each strategy. One-way, two-way, and probabilistic sensitivity analyses were performed to test the robustness of the result. The methods selected were HBS, CSB &ASE.
Results
The results showed augmented self-examination is the best strategy followed by education and lastly screening vehicles. One-way analysis showed that the results were sensitive to the labor cost, but the two-way analysis showed that results are not sensitive to cancer burden. The cost of ASE for 3 cancers (oral, cervical breast) per person is INR 150, for CSB 1200 INR, and for HBS its 650 INR.
Conclusions
ASE is the way forward in developing nations followed by empowering the community health centers and the least effective is cancer screening buses.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
462P - Limited duration of treatment with checkpoint inhibitors in complete responders, yet prolonged survival: A real-world study from India
Presenter: Nitin Murthy
Session: Poster viewing 06
463P - Cost effectiveness of palbociclib and ribociclib in metastatic breast cancer in India using ICER and QALY
Presenter: Krishnamani Kalpathi
Session: Poster viewing 06
464TiP - Phase III study of adjuvant encorafenib plus binimetinib vs placebo in fully resected stage IIB/C BRAFV600-mutated melanoma: COLUMBUS-AD study design
Presenter: Alexander van Akkooi
Session: Poster viewing 06
465TiP - Evaluation of quality of life and functional outcomes following limb salvage surgery in extremities sarcomas
Presenter: naveen kushwaha
Session: Poster viewing 06
YO2 - A case of locally advanced breast cancer with biomarker conversion successfully treated with neoadjuvant chemotherapy-immunotherapy combination
Presenter: Long Nguyen
Session: Poster viewing 06
YO3 - Metastatic Breast cancer to esophagus: A case report and review of literature
Presenter: Bhuvana J
Session: Poster viewing 06
YO4 - Succinate Dehydrogenase deficient GISTs is a diagnostic and therapeutic dilemma? : A case report.
Presenter: Nurazzahra Kamarudin
Session: Poster viewing 06
YO5 - Complete Radiologic and Pathologic Response in a Metastatic Gallbladder Adenocarcinoma Patient treated with Checkpoint Inhibitor/Chemotherapy Combination: A Case Report
Presenter: Tisha Gay Tancongco
Session: Poster viewing 06
YO7 - Orbital Metastasis in Prostrate Cancer: A Case Report
Presenter: Shabnam Rehman
Session: Poster viewing 06
YO10 - BRCA2 Mutated Recurrent Adult Granulosa Cell Tumor Treated with PARP Inhibitor
Presenter: Debapriya Mondal
Session: Poster viewing 06